Endometrial carcinoma: The prognostic impact of papillary serous carcinoma (UPSC) in relation to nuclear grade, DNA ploidy and p53 expression

Anticancer Research

Volumn 16, Issue 2, 1996, Pages 899-904

  Nordstrom B ^a   Strang, P ^a   Lindgren, A ^b   Bergstrom R ^c   Tribukait, B ^d  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c UPPSALA UNIVERSITY   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Clear cell adenocarcinoma (CCC); DNA ploidy; Endometrial carcinoma; Nuclear grad; Prognosis; Uterine papillary serious carcinoma (UPSC)

Indexed keywords

GENE PRODUCT; PROTEIN P53;

ADULT; AGE; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLEAR CELL CARCINOMA; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PAPILLARY CARCINOMA; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; ADENOCARCINOMA, CLEAR CELL; ADULT; AGED; AGED, 80 AND OVER; CYSTADENOCARCINOMA, PAPILLARY; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; METAPLASIA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; UTERINE NEOPLASMS;

EID: 0029982428     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Christopherson W: The Significance of the Pathologic Findings in Endometrial Cancer. Obstet Gynecol 13: 673-693, 1986.
2. Rosenberg P, Risberg B, Askmalm L, Simonsen E: The prognosis in early endometrial carcinoma. The importance of uterine papillary serous carcinoma (UPSC). Age, FIGO Grade, and Nuclear Grade. Acta Obstet Gynecol Scand 68: 157-163, 1989.
3. Christopherson WM, Connelly PJ, Alberhansky RC: Carcinoma of the endometrium. V. An analysis of prognosticators in patients with favourable subtypes and stage I disease. Cancer 57: 1705-1709, 1983.
4. Goff B, Kato D, Schmidt R, Ek M, Ferry J, Muntz H, Cain J, Tamimi H, Figge D, Greer B: Uterine Papillary Serous Carcinoma: Patterns of Metastatic Spread. Gynecol Oncol 54: 264-268, 1994.
5. Alberhasky RC, Connelly PJ, Christopherson WM: Carcinoma of the endometrium. IV. Mixed adenosquamous carcinoma. A clinical-pathological study of 68 cases with long-term follow-up. Am J Clin Pathol 77: 655-664, 1982.
6. Novak E: Gynecological and Obstetrical Pathology. Philadelphia: WB Saunders, 1947. 225-41.
7. Factor SM: Papillary adenocarcinoma of the endometrium with psammoma bodies. Arch Pathol 98: 201-205, 1974.
8. Koss LG: Diagnostic Cytology. Philadelphia, Lippincott, 1961, pp152.
9. Spjut HJ, Kaufman RH, and Carrig SS: Psammoma bodies in cervicovaginal smear. Acta Cytol 8: 352-355, 1964.
10. Weaver RJ: Endometrial carcinoma with psammoma bodies in the vaginal smear. Am J Obstet Gynecol 97: 869-870, 1969.
11. LiVolsi VA: Adenocarcinoma of the endometrium with psammoma bodies. Obstet Gynecol 50: 725-728, 1977.
12. Hameed K, and Morgan D: Papillary adenocarcinoma of the endometrium with psammoma bodies: Histology and fine structure. Cancer 29: 1326-1335, 1972.
13. Lauchlan SC: Tubal (serous) carcinoma of the endometrium. Arch Pathol Lab Med 105: 615-618, 1981.
14. Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R: Uterine papillary serous carcinoma. A highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol 6: 93-108, 1982.
15. Jeffrey JF, Krepart GV and Lotocki RJ: Papillary serous adenocarcinoma of the endometrium. Obstet Gynecol 67: 670-74, 1986.
16. Gallion HH, van Nagell JR, Powell DF et al: Stage I serous papillary carcinoma of the endometrium. Cancer 63: 2224-2228, 1989.
17. Sherman ME, Bitterman P, Rosenshein NB, Delgado G, and Kurman R: Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features. Am J Surg Pathol 16: 600-610, 1992.
18. Rosenberg P, Blom R, Högberg T, Simonsen E. Death Rate and Recurrence Pattern among 841 Clinical Stage 1 Endometrial cancer Patients with Special reference to Uterine Papillary Serous Carcinoma. Gynecol Oncol 57: 311-315, 1993.
19. Christopherson WM, Alberhasky RC, Connelly PJ: Carcinoma of the Endometrium. II Papillary Adenocarcinoma: A Clinical Pathological Study 46 Cases. Am J Clin Pathol 77: 534-540, 1982.
20. Chen JL, Trost DC, Wilkinson EJ: Endometrial papillary adenocarcinomas: Two clinicopathological types. Int J Gynecol Pathol 4: 279-288, 1985.
21. Ramirez-Gonzalez CE, Adamsons K, Mangual-Vazquez TY, Wallach RC: Papillary adenocarcinoma in the endometrium. Obstet Gynecol 70: 212-214, 1987.
22. Abeler VM, Kjørstad KE: Serous Papillary Carcinoma of the Endometrium: A Histopathological study of 22 cases. Gynecol Oncol 39: 266-271, 1990.
23. Burrell MO, Franklin EW III, and Powell JL: Endometrial cancer: Evaluation of spread and follow-up in one hundred eighty-nine patients with stage I or stage II disease. Am J Obstet Gynecol 144: 181-185, 1982.
24. Carcangiu ML, Chambers JT: Uterine Papillary Serous Carcinoma: A study on 108 cases with emphasis on the prognostic significance of associated endometroid carcinoma. Absence of invasion, and concomitant ovarian carcinoma. Gynecol Oncol 47: 298-305, 1992.
25. Walker AN and Mills SE: Serous papillary carcinoma of the endometrium: A clinicopathologic study of 11 cases. Diagn Gynecol Obstet 4: 261-267, 1982.
26. Hendrickson M, Ross J, Eifel P J, Cox R S, Martinez A, Kempson R. Adenocarcinoma of the endometrium: Analysis of 256 cases with carcinomas limited to the uterine corpus. Pathology review and analysis of prognostic variables. Gynecol Oncol 13: 376-392, 1982.
27. Kurman RJ, Morris HJ: Endometrial carcinoma. In: Kurman RJ, ed. Blaustein's pathology of the female genital tract. New York: Springer-Verlag, 1987: 338-373.
28. Photopoulos GJ, Carney CN, Edelman DA, Hughes RR, Fowler WC, Walton LA: Clear cell carcinoma of the endometrium. Cancer 43: 1448-1456, 1979.
29. Christopherson WM, Alberhasky RC, Connelly PJ: Carcinoma of the endometrium: I. A clinicopathologic study of clear-cell carcinoma and secretory carcinoma . Cancer 49: 1511-1523, 1982.
30. Aheler V M, Kjørstad E: Clear cell carcinoma of the endometrium: A histological and clinical study of 97 cases. Gynecol Oncol 40: 207-217, 1991.
31. Schiller W: Mesonephroma ovarii. Amer J Cancer 35: 1-21, 1939.
32. Herbst AL, Rohhoy SJ, Scully RE, Poskanzer DC: Clear-cell adenocarcinoma of the vagina and cervix in girls. Analysis of 170 registry cases. Amer J Obstet Gynecol 119: 713-724, 1974.
33. Silverberg SG, DeGiorgi LS: Clear cell carcinoma of the endometrium. Clinical, pathologic, and ultrastructural findingss. Cancer 31: 1127-1140, 1973.
34. Kurman RJ, Scully RE: Clear cell carcinoma of the endometrium. An analysis of 21 cases. Cancer 37: 872-882, 1976.
35. FIGO: Classification and staging of malignant tumors in the female pelvis. Nit J Gynecol Obstet 9: 172-179, 1971.
36. Poulsen H, Taylor CW, Sobin LH: Histological typing of female genital tract tumors. No. 13. Internationalhistologic classifcation oftumors. World Health Organization, Geneva,No 13, 1975.
37. Sobin LH, Thomas LB, Constance P & Henson: A: Coded Compendium of International Histological Classifcation of Tumours. World Health Organization. Geneva, 1978: (Ed), D.E.p. 11.
38. FIGO stages- 1988 revisions: Vulva, ovary, corpus. Gynecol. Oncol 35: 125-127, 1989.
39. Tribukait B: Flow cytometry in surgical pathology and cytology of tumors of genito-urinary tract. In: Advances in clinical cytology, Vol. 2, p. 163-89, Eds. Koss L, Coleman D, Masson, New York, 1984.
40. Castro J, Heiden T, Wang N, Tribukait B: Preparation of cell nuclei from fresh tissues for high quality DNA flow cytometry. Cytometry 14: 7938-7904, 1993.
41. Heiden T, Strang P, Stendahl U, Tribukait B: Reproducibility of flow cytometric analyses in human malignancies. Anticancer Res 10: 49-54, 1990.
42. Kjellgren O, Jonsson L: Further development of the Heyman radium packing method. Acta Radiol 3: 143-151, 1964.
43. Lawless JF: Statistical models and methods for life-time data. New York: Wiley, 1982.
44. Symonds D: Prognostic value of pathologic features and DNA analysis in endometrial carcinoma. Gynecol Oncol 39: 272-276, 1990.
45. Stendahl U, Strang P, Wagenius G, Bergstrom R, Tribukait B: Prognostic significans of proliferation in endometrial carcinoma. A multivariate analysis of clinical and flow cytometric variables. Int J Gynecol Pathol 10: 271-284, 1991.
46. Ikeda M, Watanabe Y, Nanjoh T, Noda K: Evaluation of DNA ploidy in endometrial cancer. Gynecol Oncol 50: 25-29, 1993.
47. Melchiorri C, Chieco P, Lisignoli G, Marabini A, Orlandi C: Ploidy disturbances as an early indicator of intrinsic malignancy in endometrial carcinoma. Cancer 72: 165-172, 1993.
48. Sorbe B, Risberg B, Thornthwaite J: Nuclear morphometry and DNA flow cytometry as prognostic methods for endometrial carcinoma. Int J Gynecol Cancer 4: 94-100, 1994.